SpeechVive
PrivateLast Round
Convertible Debt
Jul 7, 2020
Total Funding Raised
$3.5M
Company Overview
SpeechVive operates in Healthcare & Life Sciences and is based in Lafayette, Indiana. Its latest recorded funding round was a Convertible Debt round in July 2020.
SpeechVive is a medical device company that has developed a wearable speech aid designed to help people with Parkinson's disease speak more loudly and clearly.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Health IoT
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
SpeechVive Comparables
Compare SpeechVive with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Sound for Life | 64% | |
| Cala Health | 64% | |
| APrevent Medical Inc. | 54% |
For institutional investors. Book with your work email.
SpeechVive Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Convertible Debt | Jul 7, 2020 | ||||
| Grant | May 18, 2016 | ||||
| VC Round | May 18, 2016 | ||||
| Series A | Apr 2, 2014 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
SpeechVive Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| SideCar Angels | Convertible Debt |
| Elevate Ventures | Convertible Debt |
| NIH RADx | Grant |
| Ambassador Enterprises | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 17, 2026
Monthly visitors grew 98% MoM, reaching 1.8K.
For institutional investors. Book with your work email.
SpeechVive Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about SpeechVive's valuation, stock price, and market status.
Is SpeechVive a public or private company?
SpeechVive is a private company.
What is the current stock price of SpeechVive?
SpeechVive is a private company, so its shares have no public market price. Caplight tracks SpeechVive's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is SpeechVive worth (valuation)?
Valuation information for SpeechVive is not publicly available.
Can I buy SpeechVive stock?
SpeechVive shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was SpeechVive's last funding round?
SpeechVive's most recent funding round was Convertible Debt on July 7, 2020.
Who are the main investors in SpeechVive?
Key investors in SpeechVive include Ambassador Enterprises.
Will SpeechVive IPO soon?
No public IPO plans have been announced for SpeechVive.
How can I track SpeechVive secondary market activity?
Caplight tracks bids, offers, and trades in SpeechVive's shares on secondary markets.